Panna Sanga is a notable inventor based in Flemington, NJ (US), recognized for his contributions to the field of pharmaceuticals. He has been instrumental in developing innovative dosing regimens for long-acting injectable formulations, particularly focusing on paliperidone.

Latest Patents

Panna Sanga holds a total of 3 patents. His latest patents include methods for treating patients with long-acting injectable paliperidone palmitate formulations. One of his significant inventions provides methods for mitigating adverse changes in blood lipid levels in patients treated with paliperidone palmitate extended-release injectable suspension. This includes transitioning patients to a six-month dosing interval formulation, enhancing treatment efficacy and patient compliance.

Career Highlights

Sanga's career is marked by his work at Janssen Pharmaceutica NV, where he has made significant strides in pharmaceutical innovation. His expertise in injectable formulations has positioned him as a key player in the industry, contributing to advancements in patient care.

Collaborations

Throughout his career, Panna has collaborated with notable colleagues, including Ruth Milz and Frank Wiegand. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective treatment solutions.

Conclusion

Panna Sanga's work in the field of pharmaceuticals, particularly in the development of extended-release injectable formulations, showcases his commitment to improving patient outcomes. His innovative approaches and collaborations continue to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.